FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080935918> ?p ?o ?g. }

• W2080935918 endingPage "352" @default.
• W2080935918 startingPage "347" @default.
• W2080935918 abstract "Hepatitis C virus (HCV) infection has been found to be strikingly associated with autoimmune phenomena. The aim of the present study was to investigate the presence of various autoantibodies in patients with HCV infection. Anti-neutrophil cytoplamic antibody (ANCA), anti-dihydrolipoamide dehydrogenase (anti-E3), rheumatoid factor (RF), anti-dihydrolipoamide acetyltransferase (anti-E2), anti-SS-A/Ro (60 kD), anti-SS-A/Ro (52 kD), anti-SS-B/La, anti-topoisomerase II (anti-topo II), anti-cardiolipin (aCL), anti-dsDNA, anti-ssDNA, anti-nuclear antibodies (ANA), anti-proteinase 3 (anti-Pr3) and anti-myeloperoxidase (anti-MPO) were determined in sera from 516 patients with HCV infection, 11 with primary biliary cirrhosis (PBC) and 44 healthy controls. Assays employed were indirect immunofluoresence, the particle latex agglutination test, enzyme-linked immunosorbent assay (ELISA) and immunoblotting. ANCA, anti-E3 antibody and RF were positive in 278/516 (55.6%), 276/516 (53.3%) and 288/516 (56%) patients with HCV infection, respectively. Positivity for ANA was present in 15.8%, anti-ssDNA in 15.6%, anti-dsDNA in 8.5%, aCL in 5%, anti-SS-B/La in 4.1%, anti-SS-A/Ro (60 kD) in 3.9%, anti-E2 in 3.3% and anti-SSA/Ro (52 kD) in 1.2%, anti-MPO in 4.8%, anti-Topo II and anti-actinin in 0%. All sera with ANCA showed c-ANCA patterns and contained anti-PR3 specificity. HCV patients with ANCA showed a higher prevalence of skin involvement, anaemia, abnormal liver function and alpha-Fetoprotein (alpha-FP). HCV patients with anti-E3 antibodies showed a higher prevalence of liver cirrhosis, arthritis, abnormal liver function and elevated alpha-FP levels. The prevalence of autoantibodies was not affected by treatment with interferon-alpha (IFN-alpha). In conclusion, autoantibodies are commonly found in patients with HCV infection. There is a high prevalence of anti-E3, ANCA and RF in these patients. Proteinase 3 and E3 are the major target antigens in HCV infection. HCV may be regarded as a possible causative factor in ANCA-related vasculitis." @default.
• W2080935918 created "2016-06-24" @default.
• W2080935918 creator A5000822112 @default.
• W2080935918 creator A5008414815 @default.
• W2080935918 creator A5015489139 @default.
• W2080935918 creator A5020186215 @default.
• W2080935918 creator A5041289344 @default.
• W2080935918 creator A5082066903 @default.
• W2080935918 creator A5083256626 @default.
• W2080935918 date "2002-05-01" @default.
• W2080935918 modified "2023-09-23" @default.
• W2080935918 title "Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection" @default.
• W2080935918 cites W1552738427 @default.
• W2080935918 cites W1596855747 @default.
• W2080935918 cites W191633857 @default.
• W2080935918 cites W1964523454 @default.
• W2080935918 cites W1990944487 @default.
• W2080935918 cites W1999149249 @default.
• W2080935918 cites W2001648086 @default.
• W2080935918 cites W2006309458 @default.
• W2080935918 cites W201109084 @default.
• W2080935918 cites W2018289835 @default.
• W2080935918 cites W2021988356 @default.
• W2080935918 cites W2031198293 @default.
• W2080935918 cites W2031503440 @default.
• W2080935918 cites W2032590063 @default.
• W2080935918 cites W2069940412 @default.
• W2080935918 cites W2071643016 @default.
• W2080935918 cites W2074055488 @default.
• W2080935918 cites W2100837269 @default.
• W2080935918 cites W2101108802 @default.
• W2080935918 cites W2102286533 @default.
• W2080935918 cites W2111928792 @default.
• W2080935918 cites W2134099195 @default.
• W2080935918 cites W2152363933 @default.
• W2080935918 cites W2162725007 @default.
• W2080935918 cites W2163841316 @default.
• W2080935918 cites W2417827002 @default.
• W2080935918 cites W2418703374 @default.
• W2080935918 cites W2435997465 @default.
• W2080935918 cites W2463853646 @default.
• W2080935918 cites W41835247 @default.
• W2080935918 doi "https://doi.org/10.1046/j.1365-2249.2002.01827.x" @default.
• W2080935918 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1906401" @default.
• W2080935918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11985526" @default.
• W2080935918 hasPublicationYear "2002" @default.
• W2080935918 type Work @default.
• W2080935918 sameAs 2080935918 @default.
• W2080935918 citedByCount "59" @default.
• W2080935918 countsByYear W20809359182012 @default.
• W2080935918 countsByYear W20809359182013 @default.
• W2080935918 countsByYear W20809359182014 @default.
• W2080935918 countsByYear W20809359182015 @default.
• W2080935918 countsByYear W20809359182016 @default.
• W2080935918 countsByYear W20809359182017 @default.
• W2080935918 countsByYear W20809359182018 @default.
• W2080935918 countsByYear W20809359182019 @default.
• W2080935918 countsByYear W20809359182021 @default.
• W2080935918 countsByYear W20809359182022 @default.
• W2080935918 crossrefType "journal-article" @default.
• W2080935918 hasAuthorship W2080935918A5000822112 @default.
• W2080935918 hasAuthorship W2080935918A5008414815 @default.
• W2080935918 hasAuthorship W2080935918A5015489139 @default.
• W2080935918 hasAuthorship W2080935918A5020186215 @default.
• W2080935918 hasAuthorship W2080935918A5041289344 @default.
• W2080935918 hasAuthorship W2080935918A5082066903 @default.
• W2080935918 hasAuthorship W2080935918A5083256626 @default.
• W2080935918 hasBestOaLocation W20809359182 @default.
• W2080935918 hasConcept C153911025 @default.
• W2080935918 hasConcept C159047783 @default.
• W2080935918 hasConcept C159654299 @default.
• W2080935918 hasConcept C163764329 @default.
• W2080935918 hasConcept C203014093 @default.
• W2080935918 hasConcept C2522874641 @default.
• W2080935918 hasConcept C2776232647 @default.
• W2080935918 hasConcept C2776408679 @default.
• W2080935918 hasConcept C71924100 @default.
• W2080935918 hasConcept C86803240 @default.
• W2080935918 hasConceptScore W2080935918C153911025 @default.
• W2080935918 hasConceptScore W2080935918C159047783 @default.
• W2080935918 hasConceptScore W2080935918C159654299 @default.
• W2080935918 hasConceptScore W2080935918C163764329 @default.
• W2080935918 hasConceptScore W2080935918C203014093 @default.
• W2080935918 hasConceptScore W2080935918C2522874641 @default.
• W2080935918 hasConceptScore W2080935918C2776232647 @default.
• W2080935918 hasConceptScore W2080935918C2776408679 @default.
• W2080935918 hasConceptScore W2080935918C71924100 @default.
• W2080935918 hasConceptScore W2080935918C86803240 @default.
• W2080935918 hasIssue "2" @default.
• W2080935918 hasLocation W20809359181 @default.
• W2080935918 hasLocation W20809359182 @default.
• W2080935918 hasLocation W20809359183 @default.
• W2080935918 hasOpenAccess W2080935918 @default.
• W2080935918 hasPrimaryLocation W20809359181 @default.
• W2080935918 hasRelatedWork W1487857142 @default.
• W2080935918 hasRelatedWork W1980206759 @default.
• W2080935918 hasRelatedWork W2043104746 @default.
• W2080935918 hasRelatedWork W2050631284 @default.

• next